For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search

Print

2022 RESEARCH

- Archives -

UMass Chan working with Evaxion to evaluate vaccine candidates for gonorrhea

UMass Chan working with Evaxion to evaluate vaccine candidates for gonorrhea

UMass Chan Medical School has received a National Institutes of Health grant for preclinical development of gonorrhea vaccine candidates identified by Denmark biotech company Evaxion.

Interest in point-of-care technologies increases among health care professionals during pandemic

Interest in point-of-care technologies increases among health care professionals during pandemic

UMass Chan Medical School and UMass Lowell researchers report that interest among health care professionals in point-of-care technologies increased during the pandemic, based on results of identical surveys administered in late 2019 and late 2020.

Gang Han and colleagues develop superfluorescence, light-emitting, nanocrystal alternative to lasers

Gang Han and colleagues develop superfluorescence, light-emitting, nanocrystal alternative to lasers

Researchers at UMass Chan Medical School and North Carolina State University have developed a superfluorescence crystal nanoparticle that uses near-infrared light to safely produce laser-quality light at room temperature.

UMass Chan medical student’s research on LGBTQI+ cancer survivors selected for national conference

UMass Chan medical student’s research on LGBTQI+ cancer survivors selected for national conference

Third-year medical student Colin Burnett was invited to present his research on LGBTQI+ cancer survivors at a national conference. Burnett and his co-authors discovered that most LGBTQI+ cancer survivors did not have access to health education resources tailored to their gender and sexual identities.

UMass Chan researchers studying COVID-19 drug Paxlovid in teens and children

UMass Chan researchers studying COVID-19 drug Paxlovid in teens and children

UMass Chan Medical School pediatric researchers are working with the U.S. Food and Drug Administration and pharmaceutical company Pfizer to fine-tune understanding of appropriate dosing of Paxlovid to prevent moderate cases of COVID-19 in high-risk patients from getting worse.

UMass Chan scientists develop web app for visualizing locality of COVID variants, clinical data

UMass Chan scientists develop web app for visualizing locality of COVID variants, clinical data

Led by Doyle Ward, PhD, researchers at UMass Chan Medical School have developed a web application that allows epidemiologists, public health officials and other scientists to access genetic information about SARS-CoV-2 virus from Central Massachusetts.

‘Before Baby Relationship Checkup’ shows promise for helping couples manage perinatal stress

‘Before Baby Relationship Checkup’ shows promise for helping couples manage perinatal stress

Checking in with expectant couples in connection with prenatal obstetrical visits shows promise for reducing risk factors for perinatal mood and anxiety disorders, according to a recent study by researchers from UMass Chan Medical School and Clark University.

UMass Chan clinician-scientist Tammy Nguyen named Wylie Scholar for research on nonhealing diabetic foot ulcers

UMass Chan clinician-scientist Tammy Nguyen named Wylie Scholar for research on nonhealing diabetic foot ulcers

Vascular Cures awarded clinician-scientist Tammy T. Nguyen, MD, PhD, the 2022 Wylie Scholar Award for her research into how the diabetic immune system contributes to nonhealing ulcers.

Is COVID-19 reaching the endemic stage? UMass Chan virologist Jeremy Luban weighs in

Is COVID-19 reaching the endemic stage? UMass Chan virologist Jeremy Luban weighs in

Jeremy Luban, MD, is a physician-scientist who studies the interaction between human cells and deadly pathogens including HIV-1, Ebola virus and SARS-CoV-2. He shares his insights on what we might expect next from COVID-19 and what researchers might focus on going forward.

FDA announces recommendations based on new study highlighting serial testing with rapid antigen tests

FDA announces recommendations based on new study highlighting serial testing with rapid antigen tests

Findings from a new study led by UMass Chan Medical School researchers are the basis for a safety communication issued by the U.S. Food and Drug Administration Aug. 11 regarding serial use of at-home antigen tests for COVID-19.

1-10  of  66  items
Page  of 7